Pradaxa Warnings Were Adequate, Boehringer Ingelheim Says
Looking to avoid a wrongful death trial scheduled for December, Boehringer Ingelheim Pharmaceutical Inc. told a federal judge in Boston on Thursday that he should declare as a matter of law...To view the full article, register now.
Already a subscriber? Click here to view full article